CutCancer Final Conference 2025

Biotechnological Hub of the NIB (BTH-NIB)

The purpose of the investment project BTH-NIB is the assurance of the appropriate infrastructural conditions for the use of research and developmental opportunities in the fields of operation of the NIB.

Play Video About project      Publication

CutCancer Final Conference 2025

Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedInPrint me
We are proud to have successfully concluded the CutCancer Final Conference held on 22–23 October at the National Institute of Biology in Ljubljana, Slovenia.

We are proud to have successfully concluded the CutCancer Final Conference held on 22–23 October at the National Institute of Biology in Ljubljana, Slovenia. Under the theme “Shaping Tomorrow: Innovative Approaches in Genetic Toxicology and Cancer Research”, the event brought together leading scientists, collaborators, and stakeholders for two days of inspiring exchange.

The scientific programme covered a broad spectrum of cancer research topics, including next-generation tools in genetic toxicology, the complexity of the tumour microenvironment, and strategies for combinational treatments to fight aggressive cancers.

Special thanks to our keynote speakers: Prof. Gareth Jenkins (Swansea University) talked about the importance of multi-endpoint approaches in the development of methodologies for carcinogenicity & Prof. Mats Nilsson (Stockholm University) shed light on in situ transcriptomics to map cells, molecules, and genetic variance across tumor samples.

And to our invited speakers for their inspiring talks covering advanced genotoxicity testing and models, combinational treatments for resistant cancers, novel biomarkers and targeting the tumor microenvironment: Marc Audebert (INRAE TOXALIM), Gillian C. (Swansea University), Marta Sendra Vega (National Institute of Biology, Spanish National Research Council), Febe van Maldegem (Amsterdam UMC), Skoblar Marija (Institute of Oncology Ljubljana), Ernesto Marcos López (Standard BioTools), Andrej Porčnik (UMC Ljubljana) & Tadeja Režen (University of Ljubljana).

A key moment of the conference was the round table titled “Collaborative Microenvironments in Cancer Research”, which brought together diverse perspectives from science, clinical practice, and patient advocacy. We thank our insightful panelists: Tanja Španic (Europa Donna Slovenija), Maja Čemazar (Institute of Oncology Ljubljana), Febe van Maldegem (Amsterdam UMC), and Barbara Breznik (National Institute of Biology) for sharing their experiences and ideas on how to strengthen interdisciplinary and collaboration in cancer research.

We extend our sincere thanks to all our sponsors and supporters who helped make this event possible: Mediline Slovenia, Omega d.o.o., Labormed, Miltenyi Biotec, Kefo d.o.o., Sanolabor, d. d., Avantor, Kemomed, d.o.o. (Slovenia), SciNote – Electronic Lab Notebook, Ljubljana Tourism.

A special thank you to Standard BioTools for their engaging presentation and contribution to the scientific programme.